β‐Sitosterol improves experimental colitis in mice with a target against pathogenic bacteria

Kang Ding,Yan‐Yan Tan,Yang Ding,Yuan Fang,Xu Yang,Jian Fang,Da‐Chao Xu,Hui Zhang,Wei Lu,Meng Li,Shi‐Cai Huang,Meng‐Ling Cai,Yan Song,Yi‐Jiang Ding,Su‐Min Zhang
DOI: https://doi.org/10.1002/jcb.27853
2018-12-11
Journal of Cellular Biochemistry
Abstract:<div class="abstract-group"> <section class="article-section article-section__abstract" lang="en" data-lang="en" id="section-1-en"> <h3 class="article-section__header main abstractlang_en main">Abstract</h3> <div class="article-section__content en main"> <p>In this article, we aim to examine the novel effects of β‐sitosterol on murine experimental colitis. β‐Sitosterol significantly reduces the weight loss, colon length, and alleviated microscopic appearances of colitis induced by dextran sulfate sodium. This compound also decreases the levels of TNF‐α, IL‐6, and IL‐1β in intestinal tissue of mice with experimental colitis in a concentration‐dependent manner. β‐Sitosterol treatment to intestinal epithelial cells significantly increases expression of antimicrobial peptides and reduces survival of intracellular <i>Salmonella typhimurium</i>. These results showed the multiple effects of β‐sitosterol against pathogenic bacteria for a novel approach to the treatment of colonic inflammation.</p>
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?